51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 523 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 113 - 標的パスウェイ数 : 214

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00418132
(ClinicalTrials.gov)
August 20003/1/2007Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic SclerosisT Cell Immunity in Collagen Biosynthesis of SclerodermaScleroderma, SystemicDrug: Thalidomide;Drug: Placebo thalidomideNew York University School of MedicineNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Terminated18 Years65 YearsBoth30Phase 1United States